APA

Ference B. A., Kastelein J. J. P., Ginsberg H. N., Chapman M. J., Nicholls S. J., Ray K. K., Packard C. J., Laufs U., Brook R. D., Oliver-Williams C., Butterworth A. S., Danesh J., Smith G. D., Catapano A. L. & Sabatine M. S. (20170920). Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. : JAMA.

Chicago

Ference Brian A, Kastelein John J P, Ginsberg Henry N, Chapman M John, Nicholls Stephen J, Ray Kausik K, Packard Chris J, Laufs Ulrich, Brook Robert D, Oliver-Williams Clare, Butterworth Adam S, Danesh John, Smith George Davey, Catapano Alberico L and Sabatine Marc S. 20170920. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. : JAMA.

Harvard

Ference B. A., Kastelein J. J. P., Ginsberg H. N., Chapman M. J., Nicholls S. J., Ray K. K., Packard C. J., Laufs U., Brook R. D., Oliver-Williams C., Butterworth A. S., Danesh J., Smith G. D., Catapano A. L. and Sabatine M. S. (20170920). Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. : JAMA.

MLA

Ference Brian A, Kastelein John J P, Ginsberg Henry N, Chapman M John, Nicholls Stephen J, Ray Kausik K, Packard Chris J, Laufs Ulrich, Brook Robert D, Oliver-Williams Clare, Butterworth Adam S, Danesh John, Smith George Davey, Catapano Alberico L and Sabatine Marc S. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. : JAMA. 20170920.